Health technology company Hyperfine Research Inc said on Monday that it plans to use the world's first portable, low-cost magnetic resonance imaging (MRI) system at the bedside of patients in the neuro intensive care unit of Yale New Haven Hospital (YNHH) under an agreement with Yale School of Medicine.
Through the Point-of-Care (POC) MRI, Hyperfine aims to make MRI accessible and available anywhere, anytime, to any patient who needs it. The new MRI system can move directly to the bedside, plug into a wall outlet and operate in any healthcare setting.
In partnership with the American Heart Association, Yale New Haven Hospital (YNHH) is the first hospital to use the Hyperfine POC MRI system on patients. YNHH is helping test the clinical workflow, user interface and image quality of Hyperfine's system.
Under the two year study, the company aims to overcome barriers that have prevented the routine use of MRI on unstable neurology intensive care unit patients who cannot be transported.
To date, YNHH has completed 138 brain MRI exams of 123 patients with known, acute neuropathology, as well as ischemic stroke, hematomas, tumors and hydrocephalus. The preliminary findings of the research are expected to be announced in early 2020.
GSK releases decade-long data on Shingrix efficacy
GSK announces positive EAGLE-1 results for gepotidacin in gonorrhoea treatment
Boehringer Ingelheim reports strong growth in 2023 and accelerates late-stage pipeline
Charles River Laboratories launches AMAP to reduce animal testing reliance
PureTech completes enrollment in Phase 2b ELEVATE IPF trial for LYT-100
Cybin secures additional US patent for CYB003 breakthrough therapy programme
UroGen's UGN-103 IND accepted by FDA for bladder cancer treatment
Biophytis reinforces obesity IP with new patent application
MaaT Pharma reveals positive 18-month data for MaaT013 in GI-aGvHD
Fusion Antibodies plc secures contract for OptiPhage library development
Innate Pharma advances Sanofi-developed NK cell engager to Phase 2 for blood cancer patients